AstraZeneca Pharma India Reports Three-Fold Profit Surge in Q1

2 Jun 2023 , 01:49 PM

AstraZeneca Pharma India, a subsidiary of the British-Swedish pharmaceutical company, witnessed a remarkable profit surge for the June quarter. The company reported a net profit of Rs.10.6 crore for Q1, marking a three-fold increase compared to last year’s corresponding quarter.

1. Net sales for the quarter rose by 15.1% YoY, reaching Rs.138.10 crore.
2. The solid financial performance led to a surge of over 6% in the company’s stock price.
3. The company’s focus on innovation, research, and customer-centric approaches will be crucial in sustaining this positive momentum.

At the time of writing, AstraZeneca Pharma India’s shares were trading at Rs.3529.80. AstraZeneca Pharma India continues to strengthen its position in the Indian market, contributing to the growth of the pharmaceutical industry.